@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix ns1: <http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:> .
@prefix ns2: <http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:8j41d0a3&rows=> .
@prefix ns3: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RACKHqe_Bcp0RV0LaEf-hZi80IoTieQXKajngDbgIffi8#> .
@prefix this: <http://purl.org/np/RACKHqe_Bcp0RV0LaEf-hZi80IoTieQXKajngDbgIffi8> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  <https://uts.nlm.nih.gov/uts/umls/concept/C4045520> ns3:consider <https://uts.nlm.nih.gov/uts/umls/concept/C5203670> .
}

sub:provenance {
  sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" .
  
  sub:_version prov:value "2"^^xsd:integer .
  
  sub:assertion prov:generatedAtTime "2023-07-20T09:47:15.183305"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4692-1377;
    prov:wasDerivedFrom <https://www.ncbi.nlm.nih.gov/pubmed/32827400/> .
  
  rdf:OBJECT rdfs:label "for COVID-19 therapy" .
  
  rdf:OBJECT-POSITION rdfs:label "(252, 264)" .
  
  rdf:PREDICATE rdfs:label "considered" .
  
  rdf:PREDICATE-POSITION rdfs:label "498" .
  
  rdf:SUBJECT rdfs:label "other antibiotics like azithromycin , ivermectin , eravacycline , valrubicin , streptomycin , nitazoxanide , teicoplanin , caspofungin , and colistin ; and other agents like hydroxychloroquine , chloroquine , tocilizumab , camostat , nafamostat , carfilzomib , interferon , aprepitant , and dexamethasone" .
  
  rdf:SUBJECT-POSITION rdfs:label "(252, 264)" .
  
  rdf:Statement rdfs:label "Results Repurposing of drugs from different pharmacological groups including antivirals like remdesivir, lopinavir, ritonavir, arbidol, oseltamivir, penciclovir, favipiravir, ganciclovir, and ribavirin; other antibiotics like azithromycin, ivermectin, eravacycline, valrubicin, streptomycin, nitazoxanide, teicoplanin, caspofungin, and colistin; and other agents like hydroxychloroquine, chloroquine, tocilizumab, camostat, nafamostat, carfilzomib, interferon, aprepitant, and dexamethasone can be considered for COVID-19 therapy." .
  
  rdfs:ABSTRACT-UID ns2:50 "8j41d0a3" .
  
  rdfs:TRIPLE-UID ns1:8j41d0a3-TRIPLE-ABSTRACT-2 "8j41d0a3-TRIPLE-ABSTRACT-2" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C4045520> rdfs:label "eravacycline" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C5203670> rdfs:label "covid-19" .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "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";
    npx:hasSignature "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";
    npx:hasSignatureTarget this: .
  
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}